ATE454139T1 - Arzneimittel mit shikonin als wirkstoff - Google Patents

Arzneimittel mit shikonin als wirkstoff

Info

Publication number: ATE454139T1
Authority: AT; Austria
Prior art keywords: shikonin; active ingredient; medicinal products; alkannin; hematopathy
Prior art date: 2003-02-21

Application number

AT03815939T

Other languages

English (en)

Inventor

Feixin Wang

Original Assignee

Beijing Jbc Chinese Traditiona

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-21

Filing date

2003-02-21

Publication date

2010-01-15

2003-02-21 Application filed by Beijing Jbc Chinese Traditiona filed Critical Beijing Jbc Chinese Traditiona

2010-01-15 Application granted granted Critical

2010-01-15 Publication of ATE454139T1 publication Critical patent/ATE454139T1/de

Links

NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 title abstract 4
241001071917 Lithospermum Species 0.000 title abstract 3
UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 title abstract 3
239000004480 active ingredient Substances 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
208000023275 Autoimmune disease Diseases 0.000 abstract 1
208000032843 Hemorrhage Diseases 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT03815939T 2003-02-21 2003-02-21 Arzneimittel mit shikonin als wirkstoff ATE454139T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/CN2003/000138 WO2004073699A1 (fr)	2003-02-21	2003-02-21	Preparations pharmaceutiques dont la shikonine est le principe actif

Publications (1)

Publication Number	Publication Date
ATE454139T1 true ATE454139T1 (de)	2010-01-15

Family

ID=32873525

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03815939T ATE454139T1 (de)	2003-02-21	2003-02-21	Arzneimittel mit shikonin als wirkstoff

Country Status (7)

Country	Link
EP (1)	EP1595536B1 (de)
JP (1)	JP4372017B2 (de)
CN (1)	CN100370976C (de)
AT (1)	ATE454139T1 (de)
AU (1)	AU2003220773A1 (de)
DE (1)	DE60330914D1 (de)
WO (1)	WO2004073699A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1307987C (zh) *	2005-07-25	2007-04-04	北京羚锐伟业科技有限公司	紫草素的新用途
TWI394565B (zh) *	2006-04-07	2013-05-01	Sunten Phytotech Co Ltd	萘二酮化合物
CN101863766B (zh) *	2010-06-26	2013-06-12	上海交通大学	β-羟基异戊酰紫草素衍生物及其制备方法
EP2629765B1 (de) *	2010-10-21	2016-07-06	Hügin, Ambros	Verfahren und zubereitungen zur behandlung von infektionen mit poxviren mit einem 1,4 naphthoquinon als wirkstoff
CN102048716A (zh) *	2010-12-20	2011-05-11	昆明理工大学	对苯二酚化合物的新用途
CN104130164B (zh) *	2014-07-09	2016-05-04	上海交通大学	外消旋体紫草素萘茜母核羟基甲基化磺酸钠衍生物
AR110934A1 (es) *	2017-02-10	2019-05-15	Menicon Co Ltd	Agente inductor de tolerancia al estrés osmótico de planta y método para reducir el estrés por sequía
CN110448546A (zh) *	2019-05-13	2019-11-15	安徽医科大学	紫草素在制备治疗乙型肝炎病毒感染药物中的应用
CN114933522B (zh) *	2022-06-17	2023-10-17	石河子大学	一种紫草素类化合物的制备方法及其应用
CN115998719A (zh) *	2022-12-21	2023-04-25	右江民族医学院	去氧紫草素在制备抗幽门螺杆菌药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1046631C (zh) *	1995-03-18	1999-11-24	新疆维吾尔自治区林业科学研究院	紫草色素抑菌唇膏
CN1058290C (zh) *	1995-06-13	2000-11-08	中国科学院植物研究所	新疆紫草细胞固体两步培养生产工艺
CN1085708C (zh) *	1999-11-29	2002-05-29	徐淑梅	紫草红色素的提取方法
CN1178678C (zh) *	2001-02-22	2004-12-08	宋安麟	医疗功效广谱的紫草剂制备方法

2003
- 2003-02-21 DE DE60330914T patent/DE60330914D1/de not_active Expired - Lifetime
- 2003-02-21 CN CNB038260107A patent/CN100370976C/zh not_active Expired - Lifetime
- 2003-02-21 AU AU2003220773A patent/AU2003220773A1/en not_active Abandoned
- 2003-02-21 JP JP2004568368A patent/JP4372017B2/ja not_active Expired - Fee Related
- 2003-02-21 AT AT03815939T patent/ATE454139T1/de not_active IP Right Cessation
- 2003-02-21 WO PCT/CN2003/000138 patent/WO2004073699A1/zh not_active Ceased
- 2003-02-21 EP EP03815939A patent/EP1595536B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO2004073699A8 (fr)	2004-11-11
WO2004073699A1 (fr)	2004-09-02
EP1595536A1 (de)	2005-11-16
CN1744888A (zh)	2006-03-08
JP4372017B2 (ja)	2009-11-25
CN100370976C (zh)	2008-02-27
EP1595536B1 (de)	2010-01-06
EP1595536A4 (de)	2007-07-18
HK1085386A1 (en)	2006-08-25
DE60330914D1 (de)	2010-02-25
JP2006514663A (ja)	2006-05-11
AU2003220773A1 (en)	2004-09-09

Similar Documents

Publication	Publication Date	Title
DE602005026078D1 (de)	2011-03-10	Verwendung von Antioxidantien zur Verhinderung von Oxidation und zur Reduzierung von Wirkstoffzersetzung in wirkstoffhaltigen medizinischen Artikeln
IL139231A0 (en)	2001-11-25	Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
MX2009003504A (es)	2009-09-29	Dispositivo para suministro local y/o regional que utiliza formulaciones liquidas de agentes terapeuticos.
BRPI0415525A (pt)	2006-12-26	derivados de imidazola e seu uso como agentes farmacêuticos
WO2003096990A3 (en)	2004-02-26	Protein cages for the delivery of medical imaging and therapy
HUP0402217A2 (hu)	2005-01-28	Platinaszármazékot tartalmazó gyógyászati készítmények
CY1105818T1 (el)	2011-02-02	Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
CY1110078T1 (el)	2015-01-14	Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
DE69718734D1 (de)	2003-03-06	Bicyclische aromatische verbindungen
TR200002969T2 (tr)	2001-01-22	Farmasötik bileşim.
ATE289805T1 (de)	2005-03-15	Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
ATE454139T1 (de)	2010-01-15	Arzneimittel mit shikonin als wirkstoff
BR0116653A (pt)	2004-02-17	Medicamento contendo uma poliamina como substância ativa
NO995838L (no)	2000-01-31	Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
ATE385798T1 (de)	2008-03-15	Pharmazeutische zubereitungen enthaltend azd 2171 und zd 6126 und verwendungen
HUP0204180A2 (hu)	2003-04-28	Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
NZ538926A (en)	2006-03-31	Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
DK1196439T3 (da)	2005-12-05	Forbindelser udvisende en antibiotikaaktivitet
ATE404519T1 (de)	2008-08-15	Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen
ATE245421T1 (de)	2003-08-15	Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
MXPA02007641A (es)	2004-04-02	Uso de farmaceutico de la combinacion de fluconazol-tinidazol y su composicion para la administracion oral.
ATE334675T1 (de)	2006-08-15	Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole
UA36030A (uk)	2001-04-16	Препарат для лікування і профілактики респіраторних хвороб коней " сегп "
ES2199687A1 (es)	2004-02-16	Utilizacion de la beta-ciclodextrina en la preparacion de medicamentos para el tratamiento de las enfermedades humanas o animales causadas por parasitos pertenecientes al genero cryptosporidium.

Legal Events

Date	Code	Title	Description
2010-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties